Tancredi M, Rosengren A, Svensson A-M, et al. Excess mortality among persons with type 2 Diabetes. N Engl J Med. 2015;373(18):1720–32.

Article  CAS  PubMed  Google Scholar 

Nwaneri C, Cooper H, Bowen-Jones D. Mortality in type 2 Diabetes Mellitus: magnitude of the evidence from a systematic review and meta-analysis. Br J Diabetes Vascular Disease. 2013;13(4):192–207.

Article  Google Scholar 

Pan X-R, Li G-w, Hu Y-H, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.

Article  CAS  PubMed  Google Scholar 

Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar A, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 Diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–97.

Article  CAS  PubMed  Google Scholar 

Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. The Lancet Diabetes & Endocrinology. 2019;7(6):452–61.

Article  Google Scholar 

Viitasalo K, Hemiö K, Puttonen S, et al. Prevention of Diabetes and Cardiovascular Diseases in occupational health care: feasibility and effectiveness. Prim Care Diabetes. 2015;9(2):96–104.

Article  PubMed  Google Scholar 

Gilis-Januszewska A, Szybinski Z, Kissimova-Skarbek K, et al. Prevention of type 2 Diabetes by lifestyle intervention in primary health care setting in Poland: Diabetes in Europe Prevention using Lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Br J Diabetes Vascular Disease. 2011;11(4):198–203.

Article  CAS  Google Scholar 

Bakhtiari A, Takian A, Majdzadeh R, Haghdoost AA. Assessment and prioritization of the WHO best buys and other recommended interventions for the prevention and control of non-communicable Diseases in Iran. BMC Public Health. 2020;20(1):1–16.

Article  Google Scholar 

Sallar A, Dagogo-Jack S. Regression from prediabetes to normal glucose regulation: state of the science. Experimental Biology and Medicine. 2020;245(10):889–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hadaegh F, Derakhshan A, Zafari N, et al. Pre-diabetes tsunami: incidence rates and risk factors of pre‐Diabetes and its different phenotypes over 9 years of follow‐up. Diabet Med. 2017;34(1):69–78.

Article  CAS  PubMed  Google Scholar 

Azizi F, Hadaegh F, Hosseinpanah F, et al. Metabolic health in the Middle East and North Africa. The Lancet Diabetes & Endocrinology. 2019;7(11):866–79.

Article  Google Scholar 

Khalili D, Asgari S, Lotfaliany M, et al. Long-term effectiveness of a lifestyle intervention: a pragmatic community trial to prevent metabolic syndrome. Am J Prev Med. 2019;56(3):437–46.

Article  PubMed  Google Scholar 

Lotfaliany M, Mansournia MA, Azizi F, et al. Long-term effectiveness of a lifestyle intervention on the prevention of type 2 Diabetes in a middle-income country. Sci Rep. 2020;10(1):1–10.

Article  Google Scholar 

Azizi F, Zadeh-Vakili A, Takyar M. Review of rationale, design, and initial findings: Tehran lipid and glucose study. Int J Endocrinol Metabolism. 2018;16(4 Suppl).

Khalili D, Azizi F, Asgari S et al. Outcomes of a longitudinal population-based cohort study and pragmatic community trial: findings from 20 years of the Tehran lipid and glucose study. Int J Endocrinol Metabolism. 2018;16(4 Suppl).

Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable Disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10(1):1–15.

Article  Google Scholar 

Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for Diabetes development. The Lancet. 2012;379(9833):2279–90.

Article  Google Scholar 

Kohansal K, Ahmadi N, Hadaegh F, et al. Determinants of the progression to type 2 Diabetes and regression to normoglycemia in people with pre-diabetes: a population-based cohort study over ten years. Prim Care Diabetes. 2022;16(6):797–803.

Article  CAS  PubMed  Google Scholar 

Paprott R, Scheidt-Nave C, Heidemann C. Determinants of change in glycemic status in individuals with prediabetes: results from a nationwide cohort study in Germany. Journal of diabetes research. 2018;2018.

Lazo-Porras M, Bernabe-Ortiz A, Ruiz-Alejos A, et al. Regression from prediabetes to normal glucose levels is more frequent than progression towards Diabetes: the CRONICAS Cohort Study. Diabetes Res Clin Pract. 2020;163:107829.

Article  CAS  PubMed  Google Scholar 

Fritsche A, Wagner R, Heni M, et al. Different effects of Lifestyle intervention in high-and low-risk prediabetes: results of the Randomized Controlled prediabetes Lifestyle intervention study (PLIS). Diabetes. 2021;70(12):2785–95.

Article  CAS  PubMed  Google Scholar 

Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent Diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. The Lancet. 2008;371(9626):1783–9.

Article  Google Scholar 

Gerstein H, Miller M, Byington R et al. Action to Control Cardiovascular Risk in Diabetes Study, Group. Effects of intensive glucose lowering in type. 2008;2:2545–59.

Bancks MP, Chen H, Balasubramanyam A, et al. Type 2 Diabetes subgroups, risk for Complications, and differential effects due to an intensive lifestyle intervention. Diabetes Care. 2021;44(5):1203–10.

Article  CAS  PubMed  PubMed Central  Google Scholar